Industry Stakeholder forum on behalf of the UK AMR Diagnostics Collaborative

5th December 2018, London

NHS ENGLAND.jpg

 Hosted by NHS England on behalf of the UK AMR Diagnostic Collaborative

Overview of the day

Following on from the successful UK AMR Diagnostics Collaborative (UKADC) Launch event in July 2018, the UKADC in responding to feedback and comments received hosted a Forum & Workshop for Industry Stakeholders involved in Point of Care Diagnostics to address Antimicrobial Resistance within the UK. 

The UKADC was delighted to offer this opportunity to Industry discuss the current challenges and opportunities they envisage for accelerating the role of Point of Care Diagnostics and AMR within the UK. 

The event took place on December 5th 2018 at The Wellcome Collection in London from  08.45-14.00pm. This industry focused stakeholder event provided an opportunity for organisations to learn more about the goals of the UKADC whilst sharing ideas, suggestions and thoughts on how the Collaborative can drive forward POC Diagnostics for AMR to address the global challenge of Antimicrobial Resistance.

The aims of this event were to:

  • Work collaboratively and interactively to understand the current challenges faced when accelerating usage of solutions manufactured by industry

  • Capture the challenges and potential solutions to feed into national policy or framework for rapid point of care diagnostics in primary and secondary healthcare settings

  • Highlight opportunities for test bed working

  • Deliver these findings to system partners to assess industry versus system partners perspective of the AMR rapid diagnostics landscape

Conclusion & next steps

Our Industry attendees participated throughout the workshop sharing their perspectives, thoughts and ideas on how to create a system fit for accelerating rapid diagnostics to tackle the challenge of Antimicrobial Resistance. Key observations included:

  • Gaining approval for Assays to be adapted within the NHS was slow and confusing for many organisations

  • Leadership is lacking when it comes to diagnostics

  • Pilot studies where financially draining on organisations and resulted in very little adaption

  • Evidence required by health professionals was based on regional needs and not a national approach

  • Lack of transparency and accountability from system partners on what is required from industry

  • Severe lack of funding or monies available for diagnostics within community care

  • System partners are not effective in communicating

  • Want to see a national approach with incentives for health professionals to use rapid diagnostics

  • Does a incentivised approach to rapid diagnostics increase take up as demonstrated in Europe?


    The slides from the day can be found here


    These thoughts, shared throughout the workshop were illustrated by the team at Scriberia below. The UKADC will now speak with System Partners on April 3rd in London. Details of which can be found here if you wish to contact the UKADC then please email antibioticresistance@4allofus.org.uk

UKADCINDUSTRYSCRIBE1.jpg